View Item 

Show simple item record

The molecular biology of von Willebrand disease

dc.contributor.authorGinsburg, David W.en_US
dc.date.accessioned2010-06-01T20:09:52Z
dc.date.available2010-06-01T20:09:52Z
dc.date.issued1999-05en_US
dc.identifier.citationGinsburg, D . (1999). "The molecular biology of von Willebrand disease." Haemophilia 5(s2): 19-27. <http://hdl.handle.net/2027.42/73288>en_US
dc.identifier.issn1351-8216en_US
dc.identifier.issn1365-2516en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73288
dc.format.extent330978 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsBlackwell Science Ltden_US
dc.subject.otherVon Willebrand Factoren_US
dc.subject.otherVon Willebrand Diseaseen_US
dc.subject.otherThrombosisen_US
dc.subject.otherHaemorrhageen_US
dc.subject.otherMolecular Biologyen_US
dc.subject.otherDisease Modelsen_US
dc.subject.otherAnimalen_US
dc.subject.otherDNA Mutational Analysisen_US
dc.titleThe molecular biology of von Willebrand diseaseen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Internal Medicine and Human Genetics and Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.identifier.pmid23401896en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73288/1/j.1365-2516.1999.0050s2019.x.pdf
dc.identifier.doi10.1046/j.1365-2516.1999.0050s2019.xen_US
dc.identifier.sourceHaemophiliaen_US
dc.identifier.citedreferencevon Willebrand EA. HereditÄr Pseudohemofili. Finska LÄkarsÄllskapetes Handl 1926; 67: 7.en_US
dc.identifier.citedreferenceNilsson IM, BlombÄck M, Jorpes E, BlombÄck B, Johansson S-A. v. Willebrand’s disease and its correction with human plasma fraction 1–0. Acta Med Scand 1957; 159: 179.en_US
dc.identifier.citedreferenceGinsburg D. Hemophilia and other inherited disorders of hemostasis and thrombosis, In: Rimoin DL, Connor JM, Pyeritz RE, Emery AEH, eds. Emery and Rimoin’s Principles and Practice of Medical Genetics, New York, Churchill Livingstone, 1997: p 1651.en_US
dc.identifier.citedreferenceNichols WC & Ginsburg D. von Willebrand disease. Med 1997; 76: 1.en_US
dc.identifier.citedreferenceSadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395.en_US
dc.identifier.citedreferenceRuggeri ZM, Ware J, Ginsburg D. von Willebrand factor. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage, 1998: p 337.en_US
dc.identifier.citedreferenceWagner DD & Ginsburg D. Structure, biology and genetics of von Willebrand protein. In: Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, eds. Hematology: Basic Principles and Practice, 1994: p 1717.en_US
dc.identifier.citedreferenceSadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520.en_US
dc.identifier.citedreferenceGinsburg D, Handin RI, Bonthron DT et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Sci 1985; 228: 1401.en_US
dc.identifier.citedreferenceSadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394.en_US
dc.identifier.citedreferenceVerweij CL, de Vries CJM, Distel B et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucl Acids Res 1985; 13: 4699.en_US
dc.identifier.citedreferenceLynch DC, Zimmerman TS, Collins CJ et al. Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell 1985; 41: 49.en_US
dc.identifier.citedreferenceTitani K, Kumar S, Takio K et al. Amino acid sequence of human von Willebrand Factor. Biochem 1986; 25: 3171.en_US
dc.identifier.citedreferenceMancuso DJ, Tuley EA, Westfield LA et al. Human von Willebrand factor gene and pseudogene: Structural analysis and differentiation by polymerase chain reaction. Biochem 1991; 30: 253.en_US
dc.identifier.citedreferenceFay PJ, Kawai Y, Wagner DD et al. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Sci 1986; 232: 995.en_US
dc.identifier.citedreferenceBernardi F, Patracchini P, Gemmati D et al. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease. Hum Mol Genet 1993; 2: 545.en_US
dc.identifier.citedreferenceMohlke KL & Ginsburg D. von Willebrand disease and quantitative deficiency of von Willebrand factor. J Lab Clin Med 1997; 130: 252.en_US
dc.identifier.citedreferenceShelton-Inloes BB, Chehab FF, Mannucci PM, Federici AB, Sadler JE. Gene deletions correlate with the development of alloantibodies in von Willebrand Disease. J Clin Invest 1987; 79: 1459.en_US
dc.identifier.citedreferenceGinsburg D, Konkle BA, Gill JC, et al. Molecular basis of human von Willebrand’s disease: analysis of platelet von Willebrand factor mRNA. Proc Natl Acad Sci USA 1989; 86: 3723 – 7.en_US
dc.identifier.citedreferenceGinsburg D & Sadler JE. von Willebrand Disease: a database of point mutations, insertions, and deletions. Thromb Haemost 1993; 69: 177.en_US
dc.identifier.citedreferenceLyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424.en_US
dc.identifier.citedreferenceDent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 6306.en_US
dc.identifier.citedreferenceFurlan M, Robles R, LÄmmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223.en_US
dc.identifier.citedreferenceTsai H-M, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1. Blood 1997; 89: 1954.en_US
dc.identifier.citedreferenceCooney KA, Nichols WC, Bruck ME et al. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest 1991; 87: 1227.en_US
dc.identifier.citedreferenceRandi AM, Rabinowitz I, Mancuso DJ, Mannucci PM, Sadler JE. Molecular basis of von Willebrand disease Type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences. J Clin Invest 1991; 87: 1220.en_US
dc.identifier.citedreferenceHolmberg L, Dent JA, Schneppenheim R, Budde U, Ware J, Ruggeri ZM. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest 1993; 91: 2169.en_US
dc.identifier.citedreferenceMazurier C. von Willebrand disease masquerading as haemophilia A. Thromb Haemost 1992; 67: 391.en_US
dc.identifier.citedreferenceCacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 1991; 266: 13499.en_US
dc.identifier.citedreferenceEikenboom JCJ, Reitsma PH, Peerlinck KMJ, BriËt E. Recessive inheritance of von Willebrand’s disease type I. Lancet 1993; 341: 982.en_US
dc.identifier.citedreferenceSchneppenheim R, Budde U, Krey S et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 1996; 76: 598.en_US
dc.identifier.citedreferenceWeiss HJ, Ball AP, Mannucci PM. Incidence of severe von Willebrand’s disease. N Engl J Med 1982; 307: 127.en_US
dc.identifier.citedreferenceBerliner SA, Seligsohn U, Zivelin A, Zwang E, Sofferman G. A relatively high frequency of severe (type III) von Willebrand’s disease in Israel. Br J Haematol 1986; 62: 535.en_US
dc.identifier.citedreferenceMannucci PM, Bloom AL, Larrieu MJ, Nilsson IM, West RR. Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand’s disease in western Europe and Israel. Br J Haematol 1984; 57: 163.en_US
dc.identifier.citedreferenceZhang ZP, BlombÄck M, Nyman D, Anvret M. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Åland Islands. Proc Natl Acad Sci USA 1993; 90: 7937.en_US
dc.identifier.citedreferenceZhang ZP, BlombÄck M, Egberg N, Falk G, Anvret M. Characterization of the von Willebrand factor gene (vWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin. Genomics 1994; 21: 188.en_US
dc.identifier.citedreferenceMohlke KL, Nichols WC, Rehemtulla A et al. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing. Br J Haematol 1996; 95: 184.en_US
dc.identifier.citedreferenceRodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454.en_US
dc.identifier.citedreferenceWerner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893.en_US
dc.identifier.citedreferenceMiller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand’s disease. I. phenotypic variation within families. Blood 1979; 54: 117.en_US
dc.identifier.citedreferenceNichols WC, Lyons SE, Harrison JS, Cody RL, Ginsburg D. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. Proc Natl Acad Sci USA 1991; 88: 3857.en_US
dc.identifier.citedreferenceEikenboom JCJ, Matsushita T, Reitsma PH et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996; 88: 2433.en_US
dc.identifier.citedreferenceOrstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89.en_US
dc.identifier.citedreferenceGill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand Disease. Blood 1987; 69: 1691.en_US
dc.identifier.citedreferenceSweeney JD, Novak EK, Reddington M, Takeuchi KH, Swank RT. The RIIIS/J inbred mouse strain as a model for von Willebrand disease. Blood 1990; 76: 2258.en_US
dc.identifier.citedreferenceNichols WC, Cooney KA, Mohlke KL et al. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood 1994; 83: 3225.en_US
dc.identifier.citedreferenceMohlke KL, Nichols WC, Westrick RJ et al. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci USA 1996; 93: 15352.en_US
dc.identifier.citedreferenceMohlke KL, Purkayastha AA, Westrick RJ, Ginsburg D. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level. Genomics 1998; 54: 19.en_US
dc.identifier.citedreferenceMohlke KL, Purkayastha AA, Westrick RJ et al. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 1998; 96: 111.en_US
dc.identifier.citedreferenceGinsburg D & Bowie EJW. Molecular genetics of von Wille-brand disease. Blood 1992; 79: 2507 – 19.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2516.1999.0050s2019.x.pdf
Size:
323.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.